There are over 10,000 cases of bladder cancer diagnosed each year, with the disease four times more common in men than women. So it’s welcome news that an Addenbrooke’s urologist has helped to develop the first national guidelines on bladder cancer.
The aim is to improve the diagnosis and management of the seventh most common cancer in the UK. Affecting mainly people aged over 60, smoking and exposure to certain industrial chemicals – such as those used in rubber industries – can increase the risk.
Blood in urine is how the cancer is usually identified, however this cancer presents a wide range of differing risk to different people who have it. Bladder cancer is one of the most expensive cancers to treat, with 5,000 deaths a year.
Bill Turner, who trained in Cambridge and has been a consultant at Addenbrooke’s for 16 years, says: “This guideline makes recommendations to the NHS that should help us to focus much more on the risk to the individual, so that the correct level of assessment can be done, and the relevant treatment options can be set out by the appropriate clinical team.
“This should promote better shared decision making, including discussion of all aspects of the person’s particular cancer, and the pros and cons of treatment options, so that people can make more informed choices about their care. Our recommendations should also allow more targeted and effective use of NHS resource.”